MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer

Oncogene

Volumn 22, Issue 39, 2003, Pages 8031-8041

  Ji, Ping ^a   Diederichs, Sven ^a   Wang, Wenbing ^a   Böing, Sebastian ^a   Metzger, Ralf ^b   Schneider, Paul M ^b   Tidow, Nicola ^a   Brandt, Burkhard ^a   Buerger, Horst ^c   Bulk, Etmar ^a   Thomas, Michael ^a   Berdel, Wolfgang E ^a   Serve, Hubert ^a   Müller Tidow, Carsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

MALAT 1; Metastasis; Non small cell lung cancer; Prognostic parameter; Subtractive hybridization; Thymosin 4

Indexed keywords

ELONGATION FACTOR 1; METASTASIS ASSOCIATED IN LUNG ADENOCARCINOMA TRANSCRIPT 1; THYMOSIN BETA4; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA HYBRIDIZATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PANCREAS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344429906     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206928     Document Type: Article

References (36)

1. Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D, Kelley PM, Pebusque MJ, Theillet C, Birnbaum and Gaudray P. (1997). Cytogenet. Cell Genet., 79, 125-131.
2. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M. (2001). Proc. Natl. Acad. Sci. USA, 98, 13790-13795.
3. Brem R, Hildebrandt T, Jarsch M, Van Muijen GN and Weidle UH. (2001). Anticancer Res., 21, 1731-1740.
4. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro Jr E and Sawicki MP. (1998). Genes Chromosomes Cancer, 22, 130-137.
5. Chenchik A, Zhu YY, Diatchenko L, Li R, Hill J and Siebert PD. (1998). Gene Cloning and Analysis by RT-PCR. BioTechniques Books: Natick, MA, pp. 305-319.
6. Clark EA, Golub TR, Lander ES and Hynes RO. (2000). Nature, 406, 532-535.
7. FANTOM and RIKEN. (2002). Nature, 420, 563-573.
8. Fidler IJ. (1990). Cancer Res., 50, 6130-6138.
9. Gibson UE, Heid CA and Williams PM. (1996). Genome Res., 6, 995-1001.
10. Gingras AC, Raught B and Sonenberg N. (1999). Annu. Rev. Biochem., 68, 913-963.
11. Guru SC, Agarwal SK, Manickam P, Olufemi SE, Crabtree JS, Weisemann JM, Kester MB, Kim YS, Wang Y, Emmert-Buck MR, Liotta LA, Spiegel AM, Boguski MS, Roe BA, Collins FS, Marx SJ, Burns L and Chandrasekharappa SC. (1997). Genome Res., 7, 725-735.
12. Hesketh R. (1997). The Oncogene and Tumour Suppressor Gene FactsBook, 2nd edn. Academic Press, Harcourt Brace & Company: New York.
13. Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC, Heitmiller RF, Bertelsen AH, Sidransky D and Jen J. (1998). Cancer Res., 58, 5690-5694.
14. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris AL. (1992). Lancet, 340, 1120-1124.
15. James MR, Richard III CW, Schott JJ, Yousry C, Clark K, Bell J, Terwilliger JD, Hazan J, Dubay C and Vignal A., et al, (1994). Nat. Genet., 8, 70-76.
16. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB and Johnson DH. (2000). N. Engl. J. Med., 343, 1217-1222.
17. Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K and Nakamura Y. (2003). Oncogene, 22, 2192-2205.
18. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H and Hosokawa M. (2002). Am. J. Pathol., 160, 869-882.
19. Li X, Zimmerman A, Copeland NG, Gilbert DJ, Jenkins NA and Yin HL. (1996). Genomics, 32, 388-394.
20. Lu Z, Jiang G, Blume-Jensen P and Hunter T. (2001). Mol. Cell. Biol., 21, 4016-4031.
21. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA and You M. (2002). Clin. Cancer Res., 8, 1127-1138.
22. Müller-Tidow C, Metzger R, Kügler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B, Schneider PM, Koeffler HP, Berdel WE and Serve H. (2001). Cancer Res., 61, 647-653.
23. Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y and Yokota J. (1998). Cancer Lett., 127, 203-209.
24. Parker SL, Tong T, Bolden S and Wingo PA. (1997). CA Cancer J. Clin., 47, 5-27.
25. Rasio D, Negrini M, Manenti G, Dragani TA and Croce CM. (1995). Cancer Res., 55, 3988-3991.
26. Ridley A. (2000). Nature, 406, 466-467.
27. Shieh DB, Godleski J, Herndon II JE, Azuma T, Mercer H, Sugarbaker DJ and Kwiatkowski DJ. (1999). Cancer, 85, 47-57.
28. Shimizu K, Nagamachi Y, Tani M, Kimura K, Shiroishi T, Wakana S and Yokota J. (2000). Genomics, 65, 113-120.
29. Sorenson S, Glimelius B and Nygren P. (2001). Acta Oncol., 40, 327-339.
30. Souquet PJ and Geriniere L. (2001). Lung Cancer, 34 (Suppl 2), S155-S158.
31. Ukena D. (2001). Lung Cancer, 33 (Suppl 1), S25-S28.
32. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC and Klein-Szanto AJ. (1989). Cancer Res., 49, 4615-4621.
33. van Asseldonk M, Schepens M, de Bruijn D, Janssen B, Merkx G and Geurts van Kessel A. (2000). Genomics, 66, 35-42.
34. Weston WM, LeClair EE, Trzyna W, McHugh KM, Nugent P, Lafferty CM, Ma L, Tuan RS and Greene RM. (1999). J. Biol. Chem., 274, 13698-13703.
35. Xu G, Rong T and Lin P. (2000). Chin. Med. J. (Engl), 113, 617-620.
36. Zimmer SG, DeBenedetti A and Graff JR. (2000). Anticancer Res., 20, 1343-1351.